Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sinovac Biotech Ltd (NASDAQ:SVA)

6.94
Delayed Data
As of 3:59pm ET
 +0.04 / +0.58%
Today’s Change
4.60
Today|||52-Week Range
7.16
+17.63%
Year-to-Date
No recent news for Sinovac Biotech Ltd.

Today’s Trading

Previous close6.90
Today’s open6.94
Day’s range6.85 - 7.16
Volume344,310
Average volume (3 months)138,589
Market cap$392.7M
Dividend yield--
Data as of 3:59pm ET, 09/25/2017

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)+600.00%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+6.84%
P/E ratioNM
Price/Sales4.78
Price/Book3.19

Competitors

 Today’s
change
Today’s
% change
DEPODepomed Inc+0.07+1.19%
AVEOAveo Pharmaceuticals...-0.04-1.11%
ACIUAC Immune Ltd+0.06+0.59%
GLYCGlycoMimetics Inc+1.25+9.19%
Data as of 4:00pm ET, 09/25/2017

Financials

Last reporting dateApril 11, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$67.4M
Annual profit (last year)-$1.1M
Net profit margin-0.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
Secretary
Wei Dong Yin
Chief Financial Officer &
Vice President
Nan Wang
Corporate headquarters
Beijing, Beijing

Forecasts